Summarized by Masters of Longevity from Longevity Technology.
Junevity’s gene-network discovery platform is being adapted to identify transcriptional pathways for translating aging biology into new cosmetic interventions.
Key Takeaways
- Junevity will use its RESET platform to identify transcription factors and pathways driving human skin aging for cosmetic targets.
- Amorepacific will fund and lead product development and commercialization after Junevity's target discovery and validation.
- Junevity retains its therapeutic RESET programs while Amorepacific Ventures made a strategic investment and licensed cosmetic applications.
